• Publications
  • Influence
A comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance.
OBJECTIVE To compare enalapril 20 mg once daily with 10 mg twice daily in terms of blood pressure reduction and patient compliance. DESIGN Cross-over study of patients randomly assigned to aExpand
  • 66
  • 1
Comparison of the effects of a 7-day period of non-compliance on blood pressure control using three different antihypertensive agents
Objectives To compare blood pressure control during 7 days of drug omission in patients taking bendroflumethiazide 2.5 mg, nifedipine LA 30 mg or enalapril 20 mg once daily and, secondarily, toExpand
  • 28
Uptake of COX‐2 selective inhibitors and influence on NSAID prescribing in Northern Ireland
Rofecoxib and celecoxib have been recently introduced and promoted as ‘safer’ non‐steroidal anti‐inflammatory drugs (NSAIDs) regarding gastric toxicity. The primary aim was to measure their uptakeExpand
  • 17
A randomized comparison of a conventional dose, a low dose and alternate‐day dosing of bendrofluazide in hypertensive patients
Objective To compare 2.5 mg bendrofluazide daily (the standard antihypertensive dose), 1.25 mg bendrofluazide daily and 2.5 mg bendrofluazide on alternate days, in terms of reduction of bloodExpand
  • 25
An Assessment of Erythrocyte Lithium Concentrations as a Measure of Patient Compliance
Following oral administration of only one dose of lithium (e.g. just prior to a clinic blood test), plasma concentrations rise quickly and may appear to be in the therapeutic steady state range forExpand
  • 2
The Implications of Noncompliance with Antihypertensive Medication
SummaryGiven the clear evidence that reducing blood pressure decreases the vascular complications of hypertension, loss of efficacy represents the principal complication of noncompliance withExpand
  • 2